Colgate-Palmolive Company $CL Shares Sold by Stokes Capital Advisors LLC

Stokes Capital Advisors LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 13.3% during the 1st quarter, HoldingsChannel reports. The firm owned 68,250 shares of the company’s stock after selling 10,500 shares during the period. Stokes Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $5,817,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Teacher Retirement System of Texas grew its holdings in Colgate-Palmolive by 35.3% during the fourth quarter. Teacher Retirement System of Texas now owns 469,624 shares of the company’s stock worth $37,110,000 after acquiring an additional 122,634 shares during the period. GAMMA Investing LLC lifted its holdings in Colgate-Palmolive by 114.2% in the fourth quarter. GAMMA Investing LLC now owns 23,329 shares of the company’s stock valued at $1,843,000 after acquiring an additional 12,437 shares during the period. Grantham Mayo Van Otterloo & Co. LLC boosted its position in shares of Colgate-Palmolive by 217.0% during the 3rd quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 40,605 shares of the company’s stock worth $3,246,000 after purchasing an additional 27,796 shares in the last quarter. Avior Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive during the 4th quarter worth $1,135,000. Finally, Flputnam Investment Management Co. grew its stake in shares of Colgate-Palmolive by 7.4% during the 4th quarter. Flputnam Investment Management Co. now owns 200,972 shares of the company’s stock worth $15,881,000 after purchasing an additional 13,804 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.9%

NYSE:CL opened at $91.06 on Friday. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The stock has a fifty day simple moving average of $87.90 and a 200-day simple moving average of $87.01. The company has a market capitalization of $72.86 billion, a PE ratio of 35.43, a price-to-earnings-growth ratio of 4.84 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.22 billion. During the same period in the prior year, the company earned $0.91 EPS. The firm’s revenue was up 8.4% on a year-over-year basis. On average, equities research analysts expect that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Monday, July 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is 82.49%.

Analysts Set New Price Targets

Several analysts recently commented on CL shares. Bank of America reduced their price objective on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a research report on Friday, May 1st. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a research report on Monday, May 4th. Finally, Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.